CRBP
Price
$10.64
Change
-$0.03 (-0.28%)
Updated
Dec 4, 04:59 PM (EDT)
Capitalization
187.47M
Intraday BUY SELL Signals
ROQAF
Price
Loading...
Change
-$0.00 (-0.00%)
Updated
Loading...
Capitalization
3.12M
Intraday BUY SELL Signals
Interact to see
Advertisement

CRBP vs ROQAF

Header iconCRBP vs ROQAF Comparison
Open Charts CRBP vs ROQAFBanner chart's image
Corbus Pharmaceuticals Holdings
Price$10.64
Change-$0.03 (-0.28%)
Volume$1.27K
Capitalization187.47M
Roquefort Therapeutics
PriceLoading...
Change-$0.00 (-0.00%)
Volume$1K
Capitalization3.12M
CRBP vs ROQAF Comparison Chart in %
CRBP
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CRBP vs. ROQAF commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRBP is a Hold and ROQAF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 05, 2025
Stock price -- (CRBP: $10.67 vs. ROQAF: $0.02)
Brand notoriety: CRBP and ROQAF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRBP: 61% vs. ROQAF: 100%
Market capitalization -- CRBP: $187.47M vs. ROQAF: $3.12M
CRBP [@Biotechnology] is valued at $187.47M. ROQAF’s [@Biotechnology] market capitalization is $3.12M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRBP’s FA Score shows that 0 FA rating(s) are green whileROQAF’s FA Score has 1 green FA rating(s).

  • CRBP’s FA Score: 0 green, 5 red.
  • ROQAF’s FA Score: 1 green, 4 red.
According to our system of comparison, CRBP is a better buy in the long-term than ROQAF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRBP’s TA Score shows that 5 TA indicator(s) are bullish.

  • CRBP’s TA Score: 5 bullish, 5 bearish.

Price Growth

CRBP (@Biotechnology) experienced а -10.19% price change this week, while ROQAF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.21%. For the same industry, the average monthly price growth was +5.86%, and the average quarterly price growth was +56.03%.

Industries' Descriptions

@Biotechnology (+1.21% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRBP($187M) has a higher market cap than ROQAF($3.12M). CRBP YTD gains are higher at: -9.576 vs. ROQAF (-57.300).
CRBPROQAFCRBP / ROQAF
Capitalization187M3.12M5,990%
EBITDA-57.15MN/A-
Gain YTD-9.576-57.30017%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash117MN/A-
Total Debt2.46MN/A-
FUNDAMENTALS RATINGS
CRBP: Fundamental Ratings
CRBP
OUTLOOK RATING
1..100
60
VALUATION
overvalued / fair valued / undervalued
1..100
45
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRBP
RSI
ODDS (%)
Bullish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
80%
MACD
ODDS (%)
Bullish Trend 2 days ago
71%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 17 days ago
80%
Declines
ODDS (%)
Bearish Trend 10 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CRBP
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IBRN31.391.09
+3.61%
iShares Neuroscience and Healthcare ETF
XITK178.111.61
+0.91%
State Street® SPDR® FctSt Innvtv TechETF
MLPA48.940.32
+0.66%
Global X MLP ETF
RND30.62N/A
N/A
First Trust Bloomberg R&D Leaders ETF
ARDC13.44-0.06
-0.44%
Ares Dynamic Credit Allocation Fund

ROQAF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ROQAF has been loosely correlated with GNTA. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if ROQAF jumps, then GNTA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ROQAF
1D Price
Change %
ROQAF100%
N/A
GNTA - ROQAF
36%
Loosely correlated
-2.07%
CRBP - ROQAF
22%
Poorly correlated
+3.79%
SVRA - ROQAF
21%
Poorly correlated
+8.43%
SKYE - ROQAF
21%
Poorly correlated
+9.91%
SNTI - ROQAF
6%
Poorly correlated
+4.76%
More